DK212580A - Fremgangsmaade til fremstilling af en influenzavirumvaccine i en flydende cellekultur - Google Patents

Fremgangsmaade til fremstilling af en influenzavirumvaccine i en flydende cellekultur

Info

Publication number
DK212580A
DK212580A DK212580A DK212580A DK212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A
Authority
DK
Denmark
Prior art keywords
virum
influenza
vaccine
preparing
procedure
Prior art date
Application number
DK212580A
Other languages
English (en)
Other versions
DK154749B (da
DK154749C (da
Inventor
K K Brown
R C Stewart
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK212580(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of DK212580A publication Critical patent/DK212580A/da
Publication of DK154749B publication Critical patent/DK154749B/da
Application granted granted Critical
Publication of DK154749C publication Critical patent/DK154749C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK212580A 1979-05-15 1980-05-14 Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur DK154749C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15
US3923679 1979-05-15

Publications (3)

Publication Number Publication Date
DK212580A true DK212580A (da) 1980-11-16
DK154749B DK154749B (da) 1988-12-19
DK154749C DK154749C (da) 1989-05-16

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK212580A DK154749C (da) 1979-05-15 1980-05-14 Fremgangsmaade til fremstilling af en influenzavirusvaccine i en flydende cellekultur

Country Status (13)

Country Link
EP (1) EP0019218B2 (da)
JP (1) JPS55153723A (da)
AR (1) AR220838A1 (da)
AT (1) ATE16454T1 (da)
AU (1) AU535804B2 (da)
CA (1) CA1122527A (da)
DE (1) DE3071225D1 (da)
DK (1) DK154749C (da)
ES (1) ES8104405A1 (da)
IL (1) IL60063A0 (da)
NO (1) NO801443L (da)
RO (1) RO79525B (da)
YU (1) YU41923B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
ATE542891T1 (de) * 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur
JPH11509081A (ja) * 1994-11-16 1999-08-17 セント ジュード チルドレンズ リサーチ ホスピタル 新規の複製プロセス
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE10144906B4 (de) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
CA2586690A1 (en) 2004-11-03 2006-06-15 Novartis Vaccines And Diagnostics, Inc. Influenza vaccination
EP2022849A4 (en) 2006-05-11 2010-10-06 Chemo Sero Therapeut Res Inst METHOD FOR PROLIFERATION OF INFLUENZA VIRUS
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
AU2010212550B2 (en) 2009-02-10 2016-03-10 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (da) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
ES491517A0 (es) 1981-04-01
EP0019218B1 (de) 1985-11-13
RO79525A (ro) 1984-07-17
NO801443L (no) 1980-11-17
EP0019218A3 (en) 1981-03-25
DE3071225D1 (en) 1985-12-19
YU41923B (en) 1988-02-29
CA1122527A (en) 1982-04-27
EP0019218A2 (de) 1980-11-26
JPH0124769B2 (da) 1989-05-15
EP0019218B2 (de) 1995-03-01
IL60063A0 (en) 1980-07-31
ATE16454T1 (de) 1985-11-15
AR220838A1 (es) 1980-11-28
JPS55153723A (en) 1980-11-29
YU126580A (en) 1983-12-31
ES8104405A1 (es) 1981-04-01
AU535804B2 (en) 1984-04-05
AU5824480A (en) 1980-11-20
DK154749B (da) 1988-12-19
RO79525B (ro) 1984-09-30
DK154749C (da) 1989-05-16

Similar Documents

Publication Publication Date Title
DK154539C (da) Fremgangsmaade til fremstilling af cyclosporinholdige farmaceutiske praeparater i flydende form
DK149942C (da) Fremgangsmaade til fremstilling af en pasteurellose-vaccine
DK344478A (da) Fremgangsmaade til fremstilling af liposomer i vandig oploesning
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK468880A (da) Fremgangsmaade til fremstilling af enzymderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK212580A (da) Fremgangsmaade til fremstilling af en influenzavirumvaccine i en flydende cellekultur
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK155915C (da) Fremgangsmaade til fremstilling af pertussis-toksoid til anvendelse i vacciner
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK152218C (da) Poroest, kugleformigt gelmateriale til separationsformaal og fremgangsmaade til fremstilling af samme samt anvendelse heraf til fremstilling af et modificeret, poroest gelmateriale
DK413780A (da) Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK476180A (da) Fremgangsmaade til fremstilling af tabletter
DK148981C (da) Fremgangsmaade til fremstilling af et immobiliseret enzympraeparat
DK396880A (da) Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK143477A (da) Fremgangsmade til dyrkning af celler
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK517979A (da) Fremgangsmaade til fremstilling af alkohol
DK150479C (da) Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK165687C (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK289378A (da) Fremgangsmaade til dyrkning af virus
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner

Legal Events

Date Code Title Description
PUP Patent expired